Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-Related Macular Degenerations.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07547228
What this trial is testing

PRL3-zumab in Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age Related Macular Degeneration
Intra-IMMUSG Pte Ltd 15
Not applicableStudy completedNCT01080898
What this trial is testing

Evaluation of Optical Coherence Tomography.

Who this might be right for
Age-Related Macular DegenerationChoroidal Vessels; Anastomosis
Assistance Publique - Hôpitaux de Paris 151
Early research (Phase 1)Study completedNCT01941082
What this trial is testing

RO6867461 Administered in Single- and Multiple-Ascending Doses in Patients With Wet Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
Hoffmann-La Roche 24
Large-scale testing (Phase 3)Study completedNCT07214740
What this trial is testing

Study to Evaluate a Pegcetacoplan (Syfovre®) Prefilled Syringe

Who this might be right for
Geographic Atrophy Secondary to Age-related Macular Degeneration
Apellis Pharmaceuticals, Inc. 44
Not applicableStudy completedNCT06184360
What this trial is testing

Real-world Evaluation of BEOVU (Brolucizumab) Effectiveness and Durability for Treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD)

Who this might be right for
Neovascular (Wet) Age-related Macular Degeneration
Novartis Pharmaceuticals 2,079
Post-approval studies (Phase 4)Study completedNCT01972789
What this trial is testing

Comparison of Treatment Regimens Using Ranibizumab: Intensive (Resolution of Intra- and Sub-retinal Fluid) vs Relaxed (Resolution of Intra-retinal Fluid and/or Sub-retinal Fluid >200µm at the Foveal Centre)

Who this might be right for
Subfoveal Choroidal Neovascularization CNV Secondary to Wet Age-related Macular Degeneration AMD
Novartis Pharmaceuticals 349
Testing effectiveness (Phase 2)Looking for participantsNCT07215390
What this trial is testing

A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio

Who this might be right for
Geographic Atrophy Secondary to Age-related Macular Degeneration
Apellis Pharmaceuticals, Inc. 240
Not applicableStudy completedNCT00668213
What this trial is testing

Antioxidant Systems and Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
Vanderbilt University 143
Not applicableWithdrawnNCT02457026
What this trial is testing

Adjunctive Photodynamic Therapy + Aflibercept vs. Afilbercept Alone for PDA in NV AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Duke University
Large-scale testing (Phase 3)Ended earlyNCT02247479
What this trial is testing

A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Who this might be right for
Geographic Atrophy
Hoffmann-La Roche 906
Not applicableUnknownNCT03944070
What this trial is testing

Management of Patients With Neovascular Age-related Macular Degeneration Undergoing Cataract Surgery

Who this might be right for
Wet Macular DegenerationCataract Extraction
Ophthalmica Eye Institute 16
Not applicableUnknownNCT05635266
What this trial is testing

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

Who this might be right for
Age-Related Macular DegenerationAllergiesAlpha-Gal Syndrome+44 more
Sanguine Biosciences 20,000
Not applicableStudy completedNCT05988827
What this trial is testing

Effect of Minimizing Light Exposure Intensity on Macular Function After Cataract Surgery in Patients With Early or Intermediate AMD

Who this might be right for
Macular Degeneration, Age RelatedCataract
Elsan 42
Testing effectiveness (Phase 2)Ended earlyNCT04566445
What this trial is testing

HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005

Who this might be right for
Dry Age-related Macular Degeneration
Gyroscope Therapeutics Limited 255
Not applicableStudy completedNCT06495203
What this trial is testing

Understand the Usage of an Artificial Intelligence Technology Called DARWEN for Eye Disorders and to Find Out the Factors Influencing Treatment Frequencies in People With nAMD and RVO

Who this might be right for
Neovascular Age-related Macular DegenerationRetinal Vein Occlusion
Bayer 1,350
Not applicableLooking for participantsNCT06619405
What this trial is testing

AMD and Validation Rod-Meditated Dark Adaptation With Everyday Task Performance

Who this might be right for
Age-Related Macular Degeneration
Duke University 100
Large-scale testing (Phase 3)Active Not RecruitingNCT05112861
What this trial is testing

A 3-month Study to Compare the Safety of ONS-5010 in Vials Versus Pre-filled Syringe in Subjects With Visual Impairment Due to Retinal Disorders

Who this might be right for
Age-Related Macular DegenerationNeovascular Age-related Macular DegenerationWet Macular Degeneration+2 more
Outlook Therapeutics, Inc. 120
Post-approval studies (Phase 4)Study completedNCT02944227
What this trial is testing

Efficacy of Fixed Monthly Dosing of Ranibizumab in Neovascular Age-related Macular Degeneration

Who this might be right for
Wet Macular Degeneration
Seoul National University Hospital 20
Not applicableStudy completedNCT01712841
What this trial is testing

Non-exudative Age-related Macular Degeneration

Who this might be right for
Non-exudative Age-related Macular Degeneration
Oregon Health and Science University 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT06707753
What this trial is testing

Safety and Tolerability of AL-001 Ophthalmic Injection in Subjects with WAMD

Who this might be right for
Wet Age-related Macular Degeneration (wAMD)
Beijing Anlong Biopharmaceutical Co., Ltd. 21
Next Page